Vaxcyte, Inc.
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in …
Biotechnology
US, San Carlos [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Vaxcyte, Inc. can't present it's latest revenue by geo. area
Revenue By Geographic Areas
Vaxcyte, Inc. can't present it's latest revenue by geo. area
Historical Revenue By Segment
Last 3Y, in mil. USDVaxcyte, Inc. can't present revenue by segment
Historical Revenue By Geographic Area
Last 3Y, in mil. USDVaxcyte, Inc. can't present revenue by geo. area